Correlation Between Aslan Pharmaceuticals and Assembly Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aslan Pharmaceuticals and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aslan Pharmaceuticals and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aslan Pharmaceuticals and Assembly Biosciences, you can compare the effects of market volatilities on Aslan Pharmaceuticals and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aslan Pharmaceuticals with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aslan Pharmaceuticals and Assembly Biosciences.

Diversification Opportunities for Aslan Pharmaceuticals and Assembly Biosciences

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Aslan and Assembly is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Aslan Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aslan Pharmaceuticals are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Aslan Pharmaceuticals i.e., Aslan Pharmaceuticals and Assembly Biosciences go up and down completely randomly.

Pair Corralation between Aslan Pharmaceuticals and Assembly Biosciences

If you would invest  1,681  in Assembly Biosciences on September 1, 2024 and sell it today you would earn a total of  23.00  from holding Assembly Biosciences or generate 1.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

Aslan Pharmaceuticals  vs.  Assembly Biosciences

 Performance 
       Timeline  
Aslan Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aslan Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Aslan Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Assembly Biosciences 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Assembly Biosciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating primary indicators, Assembly Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Aslan Pharmaceuticals and Assembly Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aslan Pharmaceuticals and Assembly Biosciences

The main advantage of trading using opposite Aslan Pharmaceuticals and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aslan Pharmaceuticals position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.
The idea behind Aslan Pharmaceuticals and Assembly Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Money Managers
Screen money managers from public funds and ETFs managed around the world